Clinical Trials Directory

Trials / Sponsors / Liminal BioSciences Ltd.

Liminal BioSciences Ltd.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate
Hyperammonemia
Phase 12022-05-13
CompletedA Healthy Volunteer Study of PBI-4050
Fibrosis, Inflammation
Phase 12020-12-09
TerminatedSingle Ascending Dose Study of PBI-4547 in Healthy Subjects
Healthy Subjects
Phase 12019-09-05
CompletedEffect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects
Healthy
Phase 12018-07-17
TerminatedOpen-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
Alström Syndrome
Phase 2 / Phase 32017-10-09
TerminatedStudy to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metab
Type 2 Diabetes Mellitus, Metabolic Syndrome
Phase 22017-05-29
TerminatedStudy of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance
Cystic Fibrosis
Phase 22017-01-03
CompletedSafety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome
Inflammation and Fibrosis, Diabetes
Phase 22016-02-22
CompletedA Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibr
Idiopathic Pulmonary Fibrosis (IPF)
Phase 22015-07-01
CompletedStudy to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome
Type 2 Diabetes, Metabolic Syndrome
Phase 22015-05-01